BACKGROUND: The association between serum total cholesterol (TC), lipid-lowering drugs and cognition in the elderly is currently controversial. OBJECTIVE: To investigate the relationship between TC, lipid-lowering drugs and cognitive functions in non-demented elderly. DESIGN AND SETTING: Participants of the Cardiovascular risk factors, aging and dementia (CAIDE) study were derived from random, population-based samples previously studied in 1972, 1977, 1982 or 1987. Analyses are based on 1382 non-demented participants re-examined in 1998 after an average follow-up of 21 years. RESULTS: High midlife TC was associated with poorer late-life episodic memory and category fluency. TC decreased in most individuals over time. A more pronounced decrease was related to poorer late-life episodic memory and psychomotor speed, but not if subjects used statins. CONCLUSIONS: The TC-cognition relationship seems bidirectional. High midlife TC is associated with poorer late-life cognition, but decreasing TC after midlife may reflect poorer cognitive status. Statins may be beneficial for cognition in non-demented elderly.
RCT Entities:
BACKGROUND: The association between serum total cholesterol (TC), lipid-lowering drugs and cognition in the elderly is currently controversial. OBJECTIVE: To investigate the relationship between TC, lipid-lowering drugs and cognitive functions in non-demented elderly. DESIGN AND SETTING:Participants of the Cardiovascular risk factors, aging and dementia (CAIDE) study were derived from random, population-based samples previously studied in 1972, 1977, 1982 or 1987. Analyses are based on 1382 non-demented participants re-examined in 1998 after an average follow-up of 21 years. RESULTS: High midlife TC was associated with poorer late-life episodic memory and category fluency. TC decreased in most individuals over time. A more pronounced decrease was related to poorer late-life episodic memory and psychomotor speed, but not if subjects used statins. CONCLUSIONS: The TC-cognition relationship seems bidirectional. High midlife TC is associated with poorer late-life cognition, but decreasing TC after midlife may reflect poorer cognitive status. Statins may be beneficial for cognition in non-demented elderly.
Authors: Cynthia M Carlsson; David M Nondahl; Barbara E K Klein; Patrick E McBride; Mark A Sager; Carla R Schubert; Ronald Klein; Karen J Cruickshanks Journal: Alzheimer Dis Assoc Disord Date: 2009 Jan-Mar Impact factor: 2.703
Authors: Zhao-Xue Yin; Xiao-Ming Shi; Virginia B Kraus; Simon M Fitzgerald; Han-Zhu Qian; Jian-Wei Xu; Yi Zhai; Melanie D Sereny; Yi Zeng Journal: Age Ageing Date: 2012-03-23 Impact factor: 10.668
Authors: Melissa Lamar; Ramon A Durazo-Arvizu; Carlos J Rodriguez; Robert C Kaplan; Marisa J Perera; Jianwen Cai; Rebeca A Espinoza Giacinto; Hector M González; Martha L Daviglus Journal: J Int Neuropsychol Soc Date: 2019-09-23 Impact factor: 2.892
Authors: Jared P Reis; Catherine M Loria; Lenore J Launer; Stephen Sidney; Kiang Liu; David R Jacobs; Na Zhu; Donald M Lloyd-Jones; Ka He; Kristine Yaffe Journal: Ann Neurol Date: 2013-02-26 Impact factor: 10.422
Authors: Nicholus M Warstadt; Emily L Dennis; Neda Jahanshad; Omid Kohannim; Talia M Nir; Katie L McMahon; Greig I de Zubicaray; Grant W Montgomery; Anjali K Henders; Nicholas G Martin; John B Whitfield; Clifford R Jack; Matt A Bernstein; Michael W Weiner; Arthur W Toga; Margaret J Wright; Paul M Thompson Journal: Neurobiol Aging Date: 2014-06-02 Impact factor: 4.673
Authors: Stephen M Ostrowski; Kachael Johnson; Matthew Siefert; Sam Shank; Luigi Sironi; Benjamin Wolozin; Gary E Landreth; Assem G Ziady Journal: Neuroscience Date: 2016-05-12 Impact factor: 3.590